Literature DB >> 26241406

Serum level of C-reactive protein is not a parameter to determine the difference between viral and atypical bacterial infections.

Anyelo Durán1,2,3, Andrea González1, Lineth Delgado1, Jesús Mosquera2, Nereida Valero1,3.   

Abstract

C-reactive protein (CRP) is an acute-phase reactant that increases in the circulation in response to a variety of inflammatory stimuli. Elevated levels in serum during several infectious diseases have been reported. In this study, a highly sensitive CRP enzyme immunoassay was used to evaluate serum CRP values in patients with viral and atypical bacterial infections. Patients (n = 139) with different viral or atypical bacterial infections (systemic or respiratory) and healthy controls (n = 40) were tested for circulating CRP values. High levels of IgM antibodies against several viruses: Dengue virus (n = 36), Cytomegalovirus (n = 9), Epstein Barr virus (n = 17), Parvovirus B19 (n = 26), Herpes simplex 1 and 2 virus (n = 3) and Influenza A and B (n = 8) and against atypical bacteria: Legionella pneumophila (n = 15), Mycoplasma pneumoniae (n = 21) and Coxiella burnetii (n = 4) were found. High values of CRP in infected patients compared with controls (P < 0.001) were found; however, no significant differences between viral and atypical bacterial infections were found. Low levels of CRP in respiratory and Coxiella burnetii infections compared with exanthematic viral and other atypical bacterial infections were found. This study suggests that CRP values are useful to define viral and atypical bacterial infections compared with normal values, but, it is not useful to define type of infection.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  C-reactive protein; atypical bacteria; infection; virus

Mesh:

Substances:

Year:  2015        PMID: 26241406     DOI: 10.1002/jmv.24341

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Prenatal toxoplasmosis antibody and childhood autism.

Authors:  Marisa N Spann; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Alan S Brown
Journal:  Autism Res       Date:  2016-11-22       Impact factor: 5.216

2.  Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study.

Authors:  Maurin Lampart; Núria Zellweger; Stefano Bassetti; Sarah Tschudin-Sutter; Katharina M Rentsch; Martin Siegemund; Roland Bingisser; Stefan Osswald; Gabriela M Kuster; Raphael Twerenbold
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

3.  Evaluation of viral respiratory pathogens in children aged under five hospitalized with lower respiratory tract infections.

Authors:  Gulsen Akkoc; Ceren Dogan; Suleyman Bayraktar; Kamil Sahin; Murat Elevli
Journal:  North Clin Istanb       Date:  2022-04-14

4.  Pharmaceutical analysis of different antibiotic regimens in the treatment of lower respiratory tract infection.

Authors:  Lin Zhang; Benhong Liu; Chunbin Wang
Journal:  Exp Ther Med       Date:  2018-07-11       Impact factor: 2.447

5.  Identifying prognostic risk factors for poor outcome following COVID-19 disease among in-centre haemodialysis patients: role of inflammation and frailty.

Authors:  Heidy Hendra; Gisele Vajgel; Marilina Antonelou; Aegida Neradova; Bethia Manson; Sarah Grace Clark; Ioannis D Kostakis; Ben Caplin; Alan D Salama
Journal:  J Nephrol       Date:  2021-01-30       Impact factor: 3.902

6.  Clinical characteristics of 68 children with atypical hand, foot, and mouth disease caused by coxsackievirus A6: a single-center retrospective analysis.

Authors:  Fang-Fang Cheng; Bing-Bing Zhang; Meng-Lu Cao; Qian Zhang; Qing-Hui Chen; Zhao-Fang Hui; Jian-Mei Tian; Wen-Hua Yan
Journal:  Transl Pediatr       Date:  2022-09

7.  C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study.

Authors:  Nguyen Lam Vuong; Huynh Thi Le Duyen; Phung Khanh Lam; Dong Thi Hoai Tam; Nguyen Van Vinh Chau; Nguyen Van Kinh; Ngoun Chanpheaktra; Lucy Chai See Lum; Ernesto Pleités; Nick Keith Jones; Cameron Paul Simmons; Kerstin Rosenberger; Thomas Jaenisch; Christine Halleux; Piero Luigi Olliaro; Bridget Wills; Sophie Yacoub
Journal:  BMC Med       Date:  2020-02-17       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.